NAVIGATOR
	ENTEROSGEL
	STRUCTURE PHARMACOLOGICAL PROPERTIES UNIQUE PROPERTIES INDICATIONS FOR USE APPLICATION
	PATIENTS
	DOCTORS
	WORKERS APTECH
	DISTRIBUTORS
	OUR PRODUCTS
	ABOUT US
	CONTACTS
	OUR PARTNERS
	NEWS
	CONSULTATIONS
	Search
	search
	Site map

	NEWS
	19.09.2008  SYMPOSIUM «Atopic dermatitis in children: CURRENT STATE OF THE PROBLEM» The symposium will be held in the satellite conference"Topical issues of child dermatology at II All-Russian Congress on children's allergy and immunology. 10.04.2008  PARTICIPATION IN THE EXHIBITION IN THE RUSSIAN XV National Congress «Man and drugs» Enterosgel will be presented at the exhibition, taking place in the XV the Russian National Congress"Man and medicine." 13.02.2008  Enterosgel was presented at the 15 th International Medical Exhibition «Maternal and Child Health - 2008», at the XII Congress of Pediatric

PHARMACOLOGICAL PROPERTIES

On improving the effectiveness of the treatment occurred, and will arise in the practice physicians. The inclusion of non-invasive methods of efferent therapy, using enterosorbent in already adopted, and widely applicable treatment can significantly improve their performance. Enterosorbents - medicines, while in the bowel lumen, bind toxic substances without direct contact with blood and lead to the reduction of toxic substances in the body. There are currently regarded as an indisputable fact that enterosorbents bind and thus limit the flow of toxic substances from the intestine into the body.
Level of toxic substances from entering the bowels clearance in the body, depending on the condition of the bowel mucosa (enterogematicheskogo barrier). Therefore, the success of enterosorbtsionnoy therapy depends on the impact on enterosorbent enterogematichesky barrier.